$1.56 Billion is the total value of Deep Track Capital, LP's 52 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 52.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVCR | Buy | NOVOCURE LTD | $82,850,000 | +100.6% | 1,000,000 | +81.8% | 5.31% | +82.3% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $81,441,000 | +21.6% | 1,855,993 | +68.7% | 5.22% | +10.5% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $80,776,000 | +6.2% | 3,134,503 | +27.9% | 5.18% | -3.5% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $80,489,000 | +26.4% | 517,051 | +3.4% | 5.16% | +14.8% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $79,834,000 | +36.4% | 2,304,683 | +15.2% | 5.12% | +23.9% |
| FATE | Buy | FATE THERAPEUTICS INC | $77,540,000 | +217.0% | 2,000,000 | +378.4% | 4.97% | +187.9% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $77,122,000 | +82.0% | 786,000 | +57.2% | 4.95% | +65.4% |
| ISEE | Buy | IVERIC BIO INC | $75,735,000 | +13.2% | 4,500,000 | +12.5% | 4.86% | +2.9% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $75,712,000 | – | 463,663 | +100.0% | 4.86% | – |
| KROS | Buy | KEROS THERAPEUTICS INC | $75,061,000 | -1.3% | 1,380,306 | +6.2% | 4.81% | -10.4% |
| KURA | Buy | KURA ONCOLOGY INC | $54,865,000 | +53.7% | 3,412,000 | +33.8% | 3.52% | +39.6% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $49,080,000 | +24.3% | 3,000,000 | +23.9% | 3.15% | +12.9% |
| BEAM | Buy | BEAM THERAPEUTICS INC | $43,763,000 | -21.5% | 763,750 | +9.1% | 2.81% | -28.7% |
| IMVT | Buy | IMMUNOVANT INC | $39,808,000 | -2.2% | 7,224,613 | +51.3% | 2.55% | -11.1% |
| RPTX | Buy | REPARE THERAPEUTICS INC | $37,936,000 | -14.3% | 2,664,017 | +26.9% | 2.43% | -22.2% |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $37,017,000 | -11.2% | 2,448,200 | +28.9% | 2.37% | -19.3% |
| AGEN | New | AGENUS INC | $34,436,000 | – | 13,998,491 | +100.0% | 2.21% | – |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $33,841,000 | -37.3% | 1,541,715 | -18.9% | 2.17% | -43.1% |
| DYN | Buy | DYNE THERAPEUTICS INC | $33,740,000 | +23.8% | 3,500,000 | +52.7% | 2.16% | +12.5% |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $28,923,000 | -13.4% | 4,259,653 | +6.5% | 1.86% | -21.3% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $27,840,000 | -1.3% | 6,000,000 | +6.4% | 1.78% | -10.3% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $25,497,000 | +28.5% | 1,729,757 | +15.3% | 1.64% | +16.7% |
| NKTX | Buy | NKARTA INC | $24,055,000 | +23.9% | 2,113,795 | +67.2% | 1.54% | +12.6% |
| Sell | DICE THERAPEUTICS INC | $23,913,000 | -29.5% | 1,250,000 | -6.8% | 1.53% | -36.0% | |
| SAGE | Buy | SAGE THERAPEUTICS INC | $22,343,000 | +5.0% | 675,000 | +35.0% | 1.43% | -4.6% |
| TCDA | Buy | TRICIDA INC | $21,805,000 | -2.3% | 2,652,693 | +13.6% | 1.40% | -11.3% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $21,639,000 | -18.1% | 1,170,290 | -12.4% | 1.39% | -25.6% |
| SLN | Buy | SILENCE THERAPEUTICS PLCads | $18,080,000 | -20.4% | 951,580 | +0.1% | 1.16% | -27.7% |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $15,541,000 | -28.0% | 5,359,000 | +10.0% | 1.00% | -34.5% |
| FMTX | New | FORMA THERAPEUTICS HLDGS INC | $15,435,000 | – | 1,659,706 | +100.0% | 0.99% | – |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $15,373,000 | +15.9% | 650,000 | -13.3% | 0.99% | +5.2% |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $14,146,000 | – | 198,730 | +100.0% | 0.91% | – |
| ANAB | New | ANAPTYSBIO INC | $13,824,000 | – | 558,782 | +100.0% | 0.89% | – |
| GRTS | Buy | GRITSTONE BIO INC | $12,301,000 | -46.0% | 2,985,729 | +68.5% | 0.79% | -51.0% |
| IPSC | Buy | CENTURY THERAPEUTICS INC | $11,664,000 | +194.2% | 926,469 | +270.6% | 0.75% | +167.1% |
| HOOK | New | HOOKIPA PHARMA INC | $11,482,000 | – | 5,035,998 | +100.0% | 0.74% | – |
| PASG | Buy | PASSAGE BIO INC | $10,463,000 | -48.8% | 3,375,000 | +4.9% | 0.67% | -53.5% |
| ABOS | Buy | ACUMEN PHARMACEUTICALS INC | $10,162,000 | -22.2% | 2,599,098 | +34.5% | 0.65% | -29.3% |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $9,251,000 | – | 245,000 | +100.0% | 0.59% | – |
| GHRS | GH RESEARCH PLCordinary shares | $9,134,000 | -21.6% | 499,400 | 0.0% | 0.59% | -28.8% | |
| Sell | TENAYA THERAPEUTICS INC | $6,443,000 | -55.4% | 546,923 | -28.3% | 0.41% | -59.5% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $6,180,000 | -11.6% | 3,000,000 | 0.0% | 0.40% | -19.7% | |
| NUVB | New | NUVATION BIO INC | $6,078,000 | – | 1,155,492 | +100.0% | 0.39% | – |
| LIFE | Sell | ATYR PHARMA INC | $5,503,000 | -33.0% | 1,028,515 | -6.5% | 0.35% | -39.1% |
| NKTR | New | NEKTAR THERAPEUTICScall | $5,390,000 | – | 1,000,000 | +100.0% | 0.35% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INCput | $3,512,000 | – | 148,300 | +100.0% | 0.22% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $2,756,000 | – | 102,117 | +100.0% | 0.18% | – |
| New | VIGIL NEUROSCIENCE INC | $2,736,000 | – | 389,141 | +100.0% | 0.18% | – | |
| NKTR | NEKTAR THERAPEUTICSput | $2,695,000 | -60.1% | 500,000 | 0.0% | 0.17% | -63.7% | |
| VERV | Sell | VERVE THERAPEUTICS INC | $2,335,000 | -87.3% | 102,342 | -79.5% | 0.15% | -88.5% |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $1,595,000 | – | 382,559 | +100.0% | 0.10% | – |
| RFL | Sell | RAFAEL HLDGS INC | $261,000 | -82.1% | 104,156 | -63.5% | 0.02% | -83.5% |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCput | $0 | – | -11,700 | -100.0% | -0.14% | – |
| ONCR | Exit | ONCORUS INC | $0 | – | -600,000 | -100.0% | -0.22% | – |
| CNTB | Exit | CONNECT BIOPHARMA HLDGS LTDads | $0 | – | -647,057 | -100.0% | -0.24% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -1,050,132 | -100.0% | -0.28% | – |
| CNTA | Exit | CENTESSA PHARMACEUTICALS PLCsponsored ads | $0 | – | -400,000 | -100.0% | -0.32% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -400,000 | -100.0% | -0.47% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INCcall | $0 | – | -500,000 | -100.0% | -0.55% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.55% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -80,000 | -100.0% | -0.76% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -750,000 | -100.0% | -0.83% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -607,600 | -100.0% | -0.93% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -421,660 | -100.0% | -1.02% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -400,000 | -100.0% | -1.20% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -130,200 | -100.0% | -1.20% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -1,000,000 | -100.0% | -1.65% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -1,000,000 | -100.0% | -1.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | 8 | Q3 2023 | 7.2% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2023 | 5.7% |
| IMMUNOVANT INC | 8 | Q3 2023 | 7.2% |
| BICYCLE THERAPEUTICS PLC | 8 | Q3 2023 | 5.2% |
| BEAM THERAPEUTICS INC | 8 | Q3 2023 | 3.9% |
| 4D MOLECULAR THERAPEUTICS IN | 8 | Q3 2023 | 2.9% |
| REPARE THERAPEUTICS INC | 8 | Q3 2023 | 3.1% |
| VIRIDIAN THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| DYNE THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| SILENCE THERAPEUTICS PLC | 8 | Q3 2023 | 1.6% |
View Deep Track Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Orchard Therapeutics plc | March 20, 2023 | 19,125,150 | 10.0% |
| ARDELYX, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2023 | 1,833,437 | 3.8% |
| Aurinia Pharmaceuticals Inc. | February 14, 2023 | 324,238 | 0.2% |
| CHINOOK THERAPEUTICS, INC. | February 14, 2023 | 3,000,000 | 4.7% |
| Forma Therapeutics Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Global Blood Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| HOOKIPA Pharma Inc. | February 14, 2023 | 1,240,369 | 2.4% |
| KalVista Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Keros Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View Deep Track Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-26 |
| SC 13G | 2024-04-26 |
| SC 13G/A | 2024-04-22 |
| SC 13G | 2024-04-12 |
| SC 13G | 2024-04-05 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-15 |
| 3 | 2024-03-14 |
View Deep Track Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.